Abstract
Thymosin alpha1 (Talpha1), a 28-amino acid peptide, is a well-known immune system enhancer for the treatment of various diseases. In the present investigation, the effects of Talpha1 on the proliferation and apoptosis of human leukemia cell lines (HL-60, K562 and K562/ADM) were studied. The proliferation was significantly depressed after 96 h of treatment with Talpha1, and obvious signs of apoptosis, i.e., cell morphology, nuclei condensation and Annexin V binding, were observed thereafter. Moreover, the up-regulation of Fas/Apol (CD95) and decrease in bcl-2 anti-apoptotic gene expression were observed in apoptotic cells. The expression and the function of P-glycoprotein (P-gp) can be slightly inhibited by Talpha1. It is noteworthy that K562 and K562/ADM were more sensitive than HL-60 cells when subjected to Talpha1. Furthermore, HepG-2, the human hepatoma cell line, displayed significant less sensitivity to Talpha1 than all the human leukemia cell lines. D-Tubocurarine (TUB), a nicotinic acetylcholine receptors (nAChRs) antagonist, significantly antagonized the inhibition effects induced by Talpha1, whereas atropine, a muscarinic acetylcholine receptor antagonist, did not exhibit such effects. All the results indicate that Tal...Continue Reading
References
Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A L GoldsteinJ Meienhofer
Nov 24, 1977·Nature·S J CollinsR E Gallagher
Jul 10, 1992·Science·Y ShiD R Green
Jan 11, 1990·Nature·J SavillC Haslett
Jul 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·A L GoldsteinA White
Aug 1, 1972·British Journal of Cancer·J F KerrA R Currie
Nov 1, 1995·The Journal of Experimental Medicine·S J MartinD R Green
Jan 27, 1995·Cell·E YangS J Korsmeyer
Jan 1, 1996·British Journal of Haematology·A G TurkinaA A Stavrovskaya
Oct 31, 1996·Experientia·F J OliverA López-Rivas
Mar 1, 1997·Mechanisms of Ageing and Development·C A BaumannA L Goldstein
May 2, 1998·The EMBO Journal·C ScaffidiM E Peter
Jul 4, 1998·Brain Research. Brain Research Reviews·J P ChangeuxM Zoli
Jan 8, 1999·Peptides·A GrottesiM Paci
Jul 20, 1999·International Journal of Immunopharmacology·A P KnutsenJ D Bouhasin
Feb 26, 2000·International Journal of Immunopharmacology·R RoyA Sodhi
Jul 18, 2001·FEBS Letters·L Meng, J Ding
May 22, 2002·Journal of Neuroimmunology·Y VilligerJ-A Romand
Jun 27, 2002·Peptides·Terry W MoodyAllan L Goldstein
Jul 31, 2002·Biochemical Pharmacology·Monika Fritzer-SzekeresThomas Szekeres
Jan 30, 2003·The Journal of Biological Chemistry·Concepción S SarandesesManuel Freire
Dec 9, 2003·European Journal of Pharmacology·Delphine GimonetFrançoise Liautaud-Roger
May 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·Margaret M Mc GeeDaniela M Zisterer
Nov 18, 2004·Journal of Gastroenterology and Hepatology·Maria H Sjogren
May 26, 2005·International Immunopharmacology·Bryan L SpangeloW David Jarvis
Citations
Jun 8, 2011·International Journal of Biological Sciences·Weina LiYingqi Zhang
Jul 21, 2011·Journal of Oncology·Chia-Hwa LeeYuan-Soon Ho
Aug 5, 2015·Molecular Medicine Reports·Xuerong LiLirong Sun
Jul 24, 2010·International Journal of Pharmaceutics·Qingfeng LiuYanqiang Zhong
Jun 7, 2008·The American Journal of Emergency Medicine·Wings T Y LooMin Wang
Jun 11, 2009·Archives of Insect Biochemistry and Physiology·Majd N AljamaliRichard C Essenberg
Aug 19, 2015·Apoptosis : an International Journal on Programmed Cell Death·Xingzhen LaoHeng Zheng
May 24, 2015·Apoptosis : an International Journal on Programmed Cell Death·Yan GuoWen-chao Liu
Sep 6, 2006·Biochimica Et Biophysica Acta·Ying-zhe FanRui Wang
Apr 20, 2017·Medicine·Chao HeTian-Fu Wen
May 9, 2019·Environmental Toxicology·Jasmin Kharazmi-Khorassani, Ahmad Asoodeh
Nov 2, 2021·Frontiers in Cell and Developmental Biology·Ruiqing FuWenfei Jin
Nov 5, 2021·Chinese Medical Journal·Cheng-Lin GuoLun-Xu Liu